Form 4 holding
Director
Bellerophon Therapeutics, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 14,607
- Estimated value
- $45,282
- Report date
- 07 Jun 2023
- Price
- $3.10
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount